Fraud cases underscore new challenges for compounding ... - Atlanta

hassonlawgroup.com/.../fraud-cases-underscore-new-challenges-for-com...

14 hours ago - Fraud is a leading concern of federal investigators and the compounding pharmacies they oversee. Compounded drugs are covered by Medicare's Part D program, and they accounted for a 56 percent increase in costs over the last year, according to a June report on Medicare spending.

U.S. feds building accounting fraud case against Valeant, with former CEO, CFO at the center: Report

FDA savages Chinese API maker in warning letter

Tuesday, November 1, 2016

The FDA has savaged a Chinese API maker in a warning letter for a long list of violations, including hiding questionable products, lying to inspectors about products made at the Beijing plant and systemic data manipulation.

September 30, 2016

Wellcare Rx Investments LLC dba Denson's Specialty Pharmacy

Chicago District Office

Compounding Pharmacy/Adulteration/Misbranding

Not Issued *